Promiscuous methionyl-tRNA synthetase mediates adaptive mistranslation to protect cells against oxidative stress.

J Cell Sci

Medicinal Bioconvergence Research Center, College of Pharmacy, Seoul National University, Seoul 151-742, Korea WCU Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Suwon 443-270, Korea

Published: October 2014

Aminoacyl-tRNA synthetases (ARSs) acylate transfer (t)RNAs with amino acids. Charging tRNAs with the right amino acids is the first step in translation; therefore, the accurate and error-free functioning of ARSs is an essential prerequisite for translational fidelity. A recent study found that methionine (Met) can be incorporated into non-Met residues of proteins through methionylation of non-cognate tRNAs under conditions of oxidative stress. However, it was not understood how this mis-methionylation is achieved. Here, we report that methionyl-tRNA synthetase (MRS) is phosphorylated at Ser209 and Ser825 by extracellular signal-related kinase (ERK1/2) under conditions of stress caused by reactive oxygen species (ROS), and that this phosphorylated MRS shows increased affinity for non-cognate tRNAs with lower affinity for tRNA(Met), leading to an increase in Met residues in cellular proteins. The expression of a mutant MRS containing the substitutions S209D and S825D, mimicking dual phosphorylation, reduced ROS levels and cell death. This controlled inaccuracy of MRS seems to serve as a defense mechanism against ROS-mediated damage at the cost of translational fidelity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179492PMC
http://dx.doi.org/10.1242/jcs.152470DOI Listing

Publication Analysis

Top Keywords

methionyl-trna synthetase
8
oxidative stress
8
trnas amino
8
amino acids
8
translational fidelity
8
non-cognate trnas
8
promiscuous methionyl-trna
4
synthetase mediates
4
mediates adaptive
4
adaptive mistranslation
4

Similar Publications

A novel methionyl-tRNA synthetase inhibitor targeting gram-positive bacterial pathogens.

Antimicrob Agents Chemother

December 2024

Center for Emerging and Re-emerging Infectious Diseases, Department of Medicine, Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington, USA.

New antibiotics are needed to treat gram-positive bacterial pathogens. is a novel inhibitor of methionyl-tRNA synthetase with selective activity against gram-positive bacteria. The minimum inhibitory concentrations (MICs) against and species range from 0.

View Article and Find Full Text PDF
Article Synopsis
  • - Brucellosis, caused by the Brucella bacterium, leads to serious economic losses in livestock due to reproductive issues and reduced milk production, coupled with antibiotic resistance complicating treatment efforts.
  • - This study focuses on isolating a compound called piperolactam A from Piper betle leaves, aiming to evaluate its potential as an antibacterial agent against Brucella sp. and its mechanism of action against specific enzymes in bacteria.
  • - Through molecular docking methods, the research shows that piperolactam A exhibits strong binding affinity to leucyl-tRNA synthetase (LeuRS), suggesting it could effectively inhibit bacterial growth by disrupting protein synthesis.
View Article and Find Full Text PDF

Light-Activatable, Cell-Type Specific Labeling of the Nascent Proteome.

ACS Chem Neurosci

October 2024

Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.

Elucidating the mechanisms by which protein synthesis contributes to complex biological processes has remained a challenging endeavor. This is particularly true in the field of neuroscience, where multiple, tightly regulated periods of new protein synthesis in different cell-types are thought to facilitate intricate neurological functions, such as memory formation. Current methods for labeling the proteome have lacked the spatial and temporal resolution to accurately discriminate these overlapping and often competing windows of mRNA translation.

View Article and Find Full Text PDF

Parkinson's disease is a progressive neurodegenerative disorder marked by the death of dopaminergic neurons in the substantia nigra region of the brain. Aggregation of alpha-synuclein (α-synuclein) is a contributing factor to Parkinson's disease pathogenesis. The objective of this study is to investigate the neuroprotective effects of gut microbes on α-synuclein aggregation using both in silico and in vivo approaches.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!